Randox Covid Contracts

Debate between Gillian Keegan and Jonathan Ashworth

Wednesday 17th November 2021 Commons Chamber

[Gillian Keegan]

I will not give way until I get some facts out, so can hon. Members please bear with me?

Moreover, working with Randox made sense with respect to our cross-UK efforts against covid-19, giving us the ability to use the existing facilities in Northern Ireland for the benefit of the whole United Kingdom. Initial contracts with Randox were procured under regulations that allow us to marshal goods and services with extreme urgency in exceptional circumstances, and these were extremely exceptional circumstances, Mr Speaker. There is no question but that Randox played its part. The initial challenge that it faced was the challenge facing Governments the world over: a shortage of machinery and transport. None the less, it quickly overcame them to play a critical role in our pandemic response.

An independent assessment in June 2020, which the hon. Member for Brent Central (Dawn Butler) might like to read, found that Randox was ahead of all other labs in terms of its process, its plans and its reporting, so a six-month extension was agreed in September 2020. By March this year, Randox was actually exceeding its contract target—

[Jonathan Ashworth (Leicester South) (Lab/Co-op)]

Will the Minister give way?

[Gillian Keegan]

I will get the target out and then I shall let the right hon. Gentleman intervene.

The target that Randox exceeded, which was its contract target, was processing more than 120,000 tests in a single day.

[Jonathan Ashworth]

I am grateful to the Minister for running through the dates. She may recall that the Secretary of State for Health and Social Care came to this House in, I believe, July of last year to announce that 750,000 Randox tests that were being used in care homes had to be withdrawn because they were faulty. Subsequent to that announcement, the Government awarded a £350 million contract to Randox. Why?

[Gillian Keegan]

Why? It was because the Government were trying to get out as many tests as possible. As I said, Randox processed—[Interruption.] Just to put it into context, Randox has, to date, carried out more than 15 million tests for covid-19, and identified more than 700,000 positive cases. That is 700,000 people who might otherwise have gone on to spread the disease. As a result of this testing capacity, they received the right advice to isolate, thereby protecting their friends, their family and society at large.